Study furthers understanding of IBD
Researchers part-funded by the Medical Research Council (MRC) and the Wellcome Trust have identified how particular parts of the intestinal immune system and the bacteria in the gut can interact to alter an individual's risk of developing Inflammatory Bowel Diseases (IBD). Results are published online today in Immunity.
Using mice, the team led by Professor Graham Lord at King's College London, has shown that a protein called T-bet plays a leading role in maintaining the delicate balance between a healthy immune system and healthy gut bacteria. If researchers can find out how this protein affects inflammation in the intestine, the discovery could eventually pave the way for new ways of treating intestinal diseases such as Crohn's disease and ulcerative colitis.
Patients with inflammatory bowel diseases can experience debilitating symptoms and serious complications such as cancer. Patients may require hospitalisation and surgery, and many need to take medication throughout their life to keep their condition under control. Although the causes of IBD remain unknown, most research has pointed to a problem within the intestinal immune system. Normally, the immune system in the gut provides protection from infection; however, in patients with IBD this usually protective function turns against the trillions of harmless bacteria that live in the intestine, leading to chronic gut inflammation.
The team has shown that T-bet has a strong influence over the role of inflammation in the intestinal immune system, causing IBD. It had previously been shown that mice with T-bet removed from their immune system spontaneously developed symptoms which mimicked those of IBD in humans. However, this is the first time that scientists have been able to pin down the exact immune cells responsible for this process, and to target these cells to reverse the symptoms of IBD in mice. The team had previously shown that T-bet plays a crucial role in deciding how thousands of genes in the body's immune response are controlled.
Professor Graham Lord, Director of the NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, says: 'Inflammatory Bowel Diseases in various forms can be painful and debilitating. By improving our understanding of the role that T-bet plays in causing inflammation within the bowel, we will be much better placed to prevent inflammation and establish new lines of attack on these illnesses in the future.'
Professor David Lomas, Chair of the MRC Population and Systems Medicine Board that funded the research, says: 'This research is a clear example of how studying what goes wrong at the molecular level can give crucial insights into how immune diseases such as IBD come about. It's only then that we can begin to intervene and target parts of the immune system before they cause painful and debilitating symptoms. The MRC is committed to funding basic discoveries like this in the laboratory, which can then form part of the vital chain which leads to treatments for patients.'
The article is published in Immunity.
Journal reference: Immunity
Provided by King's College London
- Bacteria identified that may lead to inflammatory bowel disease in certain individuals Sep 16, 2010 | not rated yet | 0
- Immune system compensates for 'leaky gut' in inflammatory bowel disease susceptibility Sep 13, 2012 | not rated yet | 0
- Novel cytokine protects mice from colitis Aug 23, 2011 | not rated yet | 0
- Bacteria-immune system 'fight' can lead to chronic diseases, study suggests Aug 02, 2012 | not rated yet | 0
- Scientists discover new drug target for inflammatory bowel disease: cytokine (IL-23) Mar 31, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Calculus of Variation - Classical Mechanics
2 hours ago I'm reading Classical Mechanics (Taylor), and the 6th chapter is a basic introduction to calculus of variations. I'm super confused :confused: ...
Frictional Force Equation Doesn't Make Sense
2 hours ago Frictional Force is mathematically defined as: Ff = μ*m*g*cos(θ) , where μ is the coefficient of friction, m is the mass of the object, g is...
Calculating Steam Pressure in Closed Container
7 hours ago I am trying to calculate the volume of liquid water i need to place in a sealed container in order to obtain 10 psi of steam pressure in that closed...
Learning curve of Electromagnetism?
12 hours ago I'm taking a first year physics course and have been having a little trouble with the basics of newtons laws and forces and whatnot, though nothing...
thin glass in liquid
13 hours ago I have one question about optics because I start interested in it. If an object is placed a distance p from a thin glass lens (index of refraction...
How many joules expended for a push up?
16 hours ago Just wondering if any of you can do the calculation that well approximates the amount of joules expended by a push up.
- More from Physics Forums - Classical Physics
More news stories
(Medical Xpress)—Inflammation is an important response in the body - it helps you to kill off invaders such bacteria that could cause a harmful infection. But if it's chronic or uncontrolled, inflammation can also cause ...
Inflammatory disorders May 14, 2013 | not rated yet | 0 |
New research by medical students working in the Breathe Well Centre of Research Excellence at the UTAS School of Medicine has revealed swimming has health benefits for young people with asthma, with no adverse effects on ...
Inflammatory disorders May 10, 2013 | not rated yet | 0
An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from The University of Manchester and the University of Toronto.
Inflammatory disorders May 08, 2013 | not rated yet | 0
Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks ...
Inflammatory disorders May 07, 2013 | 4.5 / 5 (2) | 0 |
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
2 hours ago | 4.5 / 5 (2) | 0 |
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
2 hours ago | not rated yet | 0 |
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
1 hour ago | not rated yet | 0
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
1 hour ago | not rated yet | 0
There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).
1 hour ago | not rated yet | 0
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
16 hours ago | not rated yet | 0 |